Stock listing

BOATS:TCRX TScan Therapeutics, Inc. Stock

US listing (BOATS) of TScan Therapeutics, Inc. · home listing NASDAQ:TCRX

Follow TScan Therapeutics, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:TCRX

$0.224 USD +0.014 (+6.6%)

Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:TCRX

Past 3 months -78.7% · daily closes, Jul 6, 2026 – Oct 20, 2026, adjusted for splits
Day range
$0.211 – $0.234 USDOct 20, 2026
Volume
559,556 sharesOct 20, 2026
Market cap
$14.64M USDAt the close on Oct 20, 2026 · price × 65.35M shares outstanding
TScan Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:TCRX · Home$0.224 USD+0.014 (+6.6%)559,556$0.217$0.234$0.211$0.210Close on Oct 20, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:TCRX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.224+0.014+6.6%$0.217$0.234$0.211559,556
$0.210-0.021-9.0%$0.238$0.238$0.210364,123
$0.231-0.008-3.5%$0.238$0.245$0.230568,221
$0.239+0.029+13.6%$0.216$0.243$0.209878,271
$0.211-0.006-2.8%$0.224$0.228$0.201546,576
$0.217-0.021-8.9%$0.240$0.240$0.212456,372
$0.2380.0000.0%$0.240$0.249$0.230483,537
$0.238+0.010+4.3%$0.228$0.247$0.228873,346
$0.228-0.049-17.6%$0.271$0.273$0.2241,534,641
$0.277+0.002+0.7%$0.271$0.283$0.263542,100
$0.275-0.020-6.8%$0.293$0.296$0.264601,900
$0.295-0.026-8.1%$0.317$0.330$0.285749,900
$0.321+0.003+0.9%$0.330$0.330$0.316144,400
$0.318+0.003+1.0%$0.319$0.329$0.311622,700
$0.315-0.003-0.9%$0.322$0.345$0.315554,400
$0.318-0.022-6.5%$0.339$0.346$0.311753,200
$0.3400.0000.0%$0.340$0.348$0.325359,200
$0.340-0.009-2.6%$0.352$0.370$0.330381,900
$0.349-0.015-4.1%$0.369$0.369$0.340606,700
$0.364+0.009+2.5%$0.360$0.372$0.3411,081,000
$0.355+0.024+7.3%$0.333$0.360$0.330918,500
$0.331+0.019+6.1%$0.311$0.342$0.311752,900
$0.312-0.022-6.6%$0.343$0.357$0.3101,143,200
$0.334+0.003+0.9%$0.335$0.362$0.3241,096,300
$0.331+0.010+3.1%$0.330$0.340$0.321883,900
$0.321+0.015+4.9%$0.316$0.322$0.290677,200
$0.306-0.014-4.4%$0.320$0.334$0.3061,104,000
$0.320+0.002+0.6%$0.324$0.325$0.306873,100
$0.318-0.012-3.6%$0.320$0.350$0.310804,600
$0.330-0.015-4.3%$0.340$0.343$0.330704,200
$0.345-0.047-12.0%$0.380$0.380$0.3301,536,300
$0.392+0.021+5.7%$0.370$0.417$0.3651,674,000
$0.371-0.010-2.6%$0.381$0.402$0.3513,091,000
$0.381-0.285-42.8%$0.550$0.570$0.3608,517,400
$0.666-0.064-8.8%$0.723$0.770$0.656820,300
$0.730-0.024-3.2%$0.750$0.766$0.721330,100
$0.754+0.004+0.5%$0.755$0.780$0.750150,700
$0.750-0.027-3.5%$0.777$0.800$0.747287,800
$0.777-0.017-2.1%$0.778$0.792$0.77468,300
$0.794-0.005-0.6%$0.792$0.811$0.777180,600
$0.799+0.019+2.4%$0.790$0.800$0.768194,400
$0.780+0.004+0.5%$0.790$0.790$0.772136,200
$0.776+0.026+3.5%$0.750$0.789$0.750338,300
$0.750-0.075-9.1%$0.770$0.825$0.750580,100
$0.825+0.041+5.2%$0.770$0.838$0.770173,500
$0.784+0.005+0.6%$0.780$0.795$0.763352,800
$0.779+0.007+0.9%$0.768$0.789$0.741278,400
$0.772-0.001-0.1%$0.779$0.790$0.764297,600
$0.773-0.004-0.5%$0.791$0.791$0.751528,000
$0.777+0.010+1.3%$0.772$0.799$0.764248,100
$0.767-0.029-3.6%$0.800$0.800$0.762464,300
$0.796+0.033+4.3%$0.754$0.804$0.754336,300
$0.763-0.017-2.2%$0.771$0.781$0.750129,800
$0.780+0.043+5.8%$0.745$0.780$0.745298,600
$0.737+0.014+1.9%$0.716$0.758$0.716796,200
$0.723-0.020-2.7%$0.759$0.780$0.720441,400
$0.743-0.013-1.7%$0.780$0.780$0.730253,900
$0.756+0.014+1.9%$0.756$0.779$0.740430,300
$0.742-0.032-4.1%$0.775$0.798$0.733609,500
$0.774+0.006+0.8%$0.765$0.774$0.732717,300
$0.768-0.026-3.3%$0.809$0.870$0.760907,000
$0.794-0.052-6.1%$0.870$0.892$0.7901,063,100
$0.846-0.054-6.0%$0.880$0.922$0.8461,082,200
$0.900-0.040-4.3%$0.940$0.957$0.900496,300
$0.940+0.015+1.6%$0.925$0.950$0.908145,700
$0.925+0.010+1.1%$0.937$0.970$0.890299,500
Ticker
BOATS:TCRX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
BOATS
Currency
USD

What changed lately

Latest news

TScan Therapeutics Announces Strategic Reorganization to Focus on in vivo Cell Therapy for Solid Tumors

Sep 2, 2026

Closed $0.381 (-42.8%) on Sep 2, 2026

TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Aug 12, 2026

Closed $0.773 (-0.5%) on Aug 12, 2026

TScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2, a Pivotal Trial Evaluating TSC-101 in Patients with Heme Malignancies

Jul 30, 2026

Closed $0.756 (+1.9%) on Jul 30, 2026

TScan Therapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

Jun 24, 2026

TScan Therapeutics Announces Positive Initial Data from Cohort C of Ongoing ALLOHA™ Phase 1 Study Evaluating TSC-101 in Patients with Heme Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation

Jun 22, 2026

Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies

Jun 3, 2026

TScan Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

May 6, 2026

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting

Apr 27, 2026

TScan Therapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference

Apr 8, 2026

TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Mar 4, 2026

All TScan Therapeutics, Inc. news

Decks

TScan Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
18 in the last 12 months · 99 in all · newest Sep 2, 2026 · oldest 2021
Decks
10 decks · latest Sep 2, 2026

Where TScan Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:TCRX · Home listingNASDAQUnited StatesUSD
BOATS:TCRX · This pageBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about TScan Therapeutics, Inc.